Liraglutide: another reason to target prediabetes?

Murphy, Conor F; Docherty, Neil G; le Roux, Carel W

Murphy, Conor F; Docherty, Neil G; le Roux, Carel W.

Afiliação

Murphy CF; Carel W. le Roux: Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland and Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Docherty NG; Carel W. le Roux: Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland and Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
le Roux CW; Carel W. le Roux: Diabetes Complications Research Centre, Conway Institute, University College Dublin, Ireland and Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Oncotarget ; 8(59): 99203-99204, 2017 Nov 21.

Article em En | MEDLINE | ID: mdl-29245886

Palavras-chave

GLP-1; SCALE; liraglutide; obesity; prediabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google